REPARE THERAPEUTICS INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.19 USD | -0.31% |
|
-2.45% | -56.44% |
| Apr. 26 | Repare Therapeutics Inc. Announces Directorate Changes | CI |
| Feb. 28 | Repare Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Chart calendar Repare Therapeutics Inc.
95653fb829e6c71fd8bfa9.dbXIaQKoaVdN0s6vg0rvftLQerYAIPcx2ujNVQV4Ox0.ItqvDjHCJz94hYXM9BuwK6exTOlCE5VG4qCvPTUPc14Dz4AMWuUnYh-AoQ~2438818fbaaa565c2a5e47f313a373dd
Upcoming events on Repare Therapeutics Inc.
Past events on Repare Therapeutics Inc.
| 2024-04-16 03:30 pm | Bloom Burton & Co. Healthcare Investor Conference |
| 2024-03-05 10:30 am | TD Cowen Health Care Conference |
| 2024-02-28 07:05 am | Q4 2023 Earnings Release |
| 2023-11-28 10:30 am | Piper Sandler Healthcare Conference |
| 2023-11-15 08:00 am | Business Update Call |
| 2023-11-14 08:35 am | Stifel Healthcare Conference |
| 2023-11-09 07:00 am | Q3 2023 Earnings Release |
| 2023-10-13 05:30 pm | AACR-NCI-EORTC International Conference |
| 2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster number: B057 |
| 2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster number: B169 |
| 2023-10-13 12:30 pm | AACR-NCI-EORTC International Conference - Poster number: B045 |
| 2023-10-13 09:40 am | AACR-NCI-EORTC International Conference - Abstract number: 35396 |
| 2023-10-12 12:30 pm | AACR-NCI-EORTC International Conference - Poster number: A123 |
| 2023-10-12 12:30 pm | AACR-NCI-EORTC International Conference - Poster number: A023 |
| 2023-09-13 11:30 am | Morgan Stanley Global Healthcare Conference |
| 2023-08-09 04:05 pm | Q2 2023 Earnings Release |
| 2023-06-14 05:00 pm | Goldman Sachs Global Healthcare Conference |
| 2023-06-08 10:00 am | Annual General Meeting |
| 2023-06-07 04:30 pm | MYTHIC Phase 1 Trial Results Call |
| 2023-05-09 04:05 pm | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,14 1,07 -87.4% | 7,60 3,93 93.62% | 132 122 7.81% | 51,1 59,8 -14.48% | 45,2 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -53,4 -50,4 -5.93% | -107 -111 3.46% | -17,8 -28,6 37.67% | -114 -77,4 -47.65% | -126 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -54,3 -52,3 -3.86% | -109 -110 1.46% | -19,8 -30,8 35.69% | -116 -103 -13.1% | -126 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -54,7 -54,4 -0.72% | -109 -109 0.55% | -13,9 -26,6 47.79% | -103 -87,1 -18.42% | -119 |
|
Net income Million USD | Released Forecast Spread | -27,2 | -53,4 -54,6 2.19% | -107 -109 2.25% | -29,0 -28,0 -3.57% | -93,8 -76,7 -22.33% | -116 |
|
EPS USD | Released Forecast Spread | 0,00 | -2,66 -2,60 -2.31% | -2,83 -2,76 -2.44% | -0,69 -0,70 0.82% | -2,23 -2,01 -10.85% | -2,68 |
| Announcement Date | 29/05/20 | 04/03/21 | 01/03/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6,88 3,28 109.87% | 0,41 1,96 -79.18% | 0,68 4,53 -84.99% | 113 29,3 284.43% | 18,2 8,33 118.5% | 5,68 6,12 -7.22% | 30,2 7,68 293.7% | 2,16 6,31 -65.79% | 13,0 18,9 -31.08% | 38,4 | 2,40 | 2,57 | 2,91 | 4,70 |
|
EBIT Million USD | Released Forecast Spread | -28,7 -30,2 4.89% | -34,8 -34,8 -0.22% | -38,7 -32,0 -21.18% | 73,4 -9,65 860.98% | -19,6 -30,9 36.4% | -34,7 -33,9 -2.42% | -12,3 -33,4 63.35% | -38,4 -36,6 -5.06% | -30,9 -22,4 -37.66% | -4,60 | -41,0 | -41,0 | -41,3 | -39,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -28,7 -25,9 -10.68% | -34,7 -35,2 1.21% | -38,1 -35,2 -8.2% | 75,5 -37,5 301.61% | -16,6 -28,9 42.38% | -31,3 -32,4 3.31% | -8,84 -31,7 72.11% | -35,2 -35,5 0.93% | -27,8 -22,2 -25.28% | -3,68 | -38,4 | -38,8 | -39,4 | -38,3 |
|
Net income Million USD | Released Forecast Spread | -28,3 -28,8 1.66% | -34,8 -35,2 1.12% | -38,1 -35,2 -8.3% | 75,5 -37,5 301.47% | -31,7 -31,1 -1.75% | -34,9 -32,4 -7.85% | -11,9 -31,7 62.29% | -18,9 -35,5 46.83% | -28,0 -20,0 -40.34% | -2,34 | -38,2 | -38,6 | -39,2 | -38,3 |
|
EPS USD | Released Forecast Spread | -0,71 -0,72 1.16% | -0,83 -0,87 4.6% | -0,91 -0,85 -7.48% | 1,71 -0,41 517.07% | -0,75 -0,74 -2.04% | -0,83 -0,80 -4.18% | -0,28 -0,80 65.12% | -0,45 -0,88 48.67% | -0,67 -0,33 -101.81% | -0,02 | -0,89 | -0,90 | -0,90 | -0,89 |
| Announcement Date | 01/03/22 | 05/05/22 | 04/08/22 | 09/11/22 | 28/02/23 | 09/05/23 | 09/08/23 | 09/11/23 | 28/02/24 | - | - | - | - | - |
| Today 04:05 pm | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 am | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 am | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 am | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Repare Therapeutics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RPTX Stock
- Calendar Repare Therapeutics Inc.
